Cârstea, A.P.; Mită, A.; Fortofoiu, M.-C.; Doica, I.P.; Cârstea, D.; Beznă, C.M.; Negroiu, C.E.; Diaconu, I.-D.; Georgescu, A.-R.; Kamal, A.M.;
et al. How Dexamethasone Used in Anti-COVID-19 Therapy Influenced Antihypertensive Treatment in Patients with SARS-CoV-2. Healthcare 2023, 11, 1399.
https://doi.org/10.3390/healthcare11101399
AMA Style
Cârstea AP, Mită A, Fortofoiu M-C, Doica IP, Cârstea D, Beznă CM, Negroiu CE, Diaconu I-D, Georgescu A-R, Kamal AM,
et al. How Dexamethasone Used in Anti-COVID-19 Therapy Influenced Antihypertensive Treatment in Patients with SARS-CoV-2. Healthcare. 2023; 11(10):1399.
https://doi.org/10.3390/healthcare11101399
Chicago/Turabian Style
Cârstea, Andrei Puiu, Adrian Mită, Mircea-Cătălin Fortofoiu, Irina Paula Doica, Doina Cârstea, Cristina Maria Beznă, Cristina Elena Negroiu, Ileana-Diana Diaconu, Andreea-Roberta Georgescu, Adina Maria Kamal,
and et al. 2023. "How Dexamethasone Used in Anti-COVID-19 Therapy Influenced Antihypertensive Treatment in Patients with SARS-CoV-2" Healthcare 11, no. 10: 1399.
https://doi.org/10.3390/healthcare11101399
APA Style
Cârstea, A. P., Mită, A., Fortofoiu, M.-C., Doica, I. P., Cârstea, D., Beznă, C. M., Negroiu, C. E., Diaconu, I.-D., Georgescu, A.-R., Kamal, A. M., Mahler, B., Grigorie, A.-G., & Dobrinescu, G. A.
(2023). How Dexamethasone Used in Anti-COVID-19 Therapy Influenced Antihypertensive Treatment in Patients with SARS-CoV-2. Healthcare, 11(10), 1399.
https://doi.org/10.3390/healthcare11101399